This worked out well.
No clarity on peer review, patents, TGA Provisional Approval, lack of public KOL endorsement, lack of institutional investment, if they will guzump all the timelines to push for a DMOAD label before NDA whilst there is absolutely no clear pathway.
I could say I told you so, so I will.
- Forums
- ASX - By Stock
- PAR
- PAR Investor Meeting - Questions from HC
PAR Investor Meeting - Questions from HC, page-58
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.0¢ |
Change
-0.010(4.17%) |
Mkt cap ! $80.48M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 22.5¢ | $167.1K | 714.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 120730 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 49999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 120730 | 0.220 |
7 | 128954 | 0.215 |
12 | 201568 | 0.210 |
8 | 108042 | 0.205 |
30 | 839672 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 49999 | 1 |
0.235 | 2500 | 1 |
0.240 | 44600 | 1 |
0.245 | 145349 | 4 |
0.250 | 151040 | 6 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online